SARS-CoV-2 Variants, Vaccines, and Immune Responses
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Coronaviruses".
Deadline for manuscript submissions: closed (31 January 2025) | Viewed by 667
Special Issue Editor
Interests: innate immunity; antagonistic proteins; arboviruses; vaccines
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Our immune system responds promptly to the attack of pathogens in order to limit their spread in the body and prevent the development of disease. However, several factors affect the immune system’s efficiency. Virus genetic evolution, which determines antigenic variations, causes virus’ escape from the host’s acquired immunity, such as that induced by vaccines. A striking example of recent days is SARS-CoV-2, whose extremely rapid genetic evolution has led to the emergence of viral variants capable of escaping vaccine protection. In this Special Issue, researches highlighting the relationship between SARS-CoV-2 and host immune responses, mechanisms for enhancing SARS-CoV-2 immunity, or the viral escape strategies from the immune system to induce symptomatic infection are welcome.
You may choose our Joint Special Issue in Vaccines.
Dr. Gianni Gori Savellini
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- acquired immunity
- vaccine
- virus escape
- virus evolution
- SARS-CoV-2 variants
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
